Severe Neonatal Hyperbilirubinemia in Crigler-Najjar Syndrome Model Mice Can Be Reversed With Zinc Protoporphyrin

被引:10
|
作者
Fujiwara, Ryoichi [1 ,2 ,3 ]
Mitsugi, Ryo [3 ]
Uemura, Asuka [3 ]
Itoh, Tomoo [3 ]
Tukey, Robert H. [4 ]
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-70376 Stuttgart, Germany
[2] Univ Tubingen, Dept Biochem & Pharm, Tubingen, Germany
[3] Kitasato Univ, Dept Pharmaceut, Sch Pharm, Tokyo, Japan
[4] Univ Calif San Diego, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92093 USA
关键词
UDP-GLUCURONOSYLTRANSFERASE; 1A1; SERUM BILIRUBIN; HEME OXYGENASE; NONALCOHOLIC STEATOHEPATITIS; BILIVERDIN REDUCTASE; REDUCED EXPRESSION; UDP-GLUCURONOSYLTRANSFERASE-1;
D O I
10.1002/hep4.1082
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Neurotoxic bilirubin is solely conjugated by UDP-glucuronosyltransferase (UGT) 1A1. Due to an inadequate function of UGT1A1, human neonates develop mild to severe physiological hyperbilirubinemia. Accumulation of bilirubin in the brain leads to the onset of irreversible brain damage called kernicterus. Breastfeeding is one of the most significant factors that increase the risk of developing kernicterus in infants. Why does the most natural way of feeding increase the risk of brain damage or even death? This question leads to the hypothesis that breast milk-induced neonatal hyperbilirubinemia might bring certain benefits to the body. One of the barriers to answering the above question is the lack of animal models that display mild to severe neonatal hyperbilirubinemia. A mouse model that develops neonatal hyperbilirubinemia was previously developed by a knockout of the Ugt1 locus. Deletion of Ugt1a1 results in neonatal lethality from bilirubin neurotoxicity. Bilirubin is the end product of heme catabolism in which heme oxygenase-I is largely involved. When zinc protoporphyrin, an inhibitor of heme oxygenase I, was administered to newborn Ugt1(-/-) mice, serum bilirubin levels dropped dramatically, rescuing the mice from bilirubin-induced neonatal lethality. Zinc protoporphyrin-treated Ugt1(-/-) mice developed normally as adults capable of reproducing, but their newborns showed even more severe hyperbilirubinemia. Microarray analysis of the hyperbilirubinemic livers indicated that a number of genes associated with nucleotide, transport, and immune response were significantly down-regulated in a serum bilirubin level-dependent manner. Conclusion: Our study provides an opportunity to advance the development of effective therapeutics to effectively and rapidly prevent bilirubin-induced toxicity. Neonatal hyperbilirubinemia has various impacts on the body that could be driven by the antioxidant property of bilirubin.
引用
收藏
页码:792 / 802
页数:11
相关论文
共 50 条
  • [41] Optimization of GeneRide-Encoding UGT1A1 Vector Improved Efficacy in a Mouse Model of Crigler-Najjar Syndrome
    Ko, Chih-Wei
    Bastille, Amy
    Zhang, Shengwen
    McCarthy, Elizabeth
    Gordo, Susana
    Vora, Jenisha
    Frank, Dylan
    Ramesh, Nikhil
    Liao, Jing
    Drouin, Lauren
    Hebben, Matthias
    Chiang, Kyle
    Padmashali, Roshan
    Gupta, Ankit
    Choi, Vivian
    Chau, Nelson
    Xiong, Qiang
    MOLECULAR THERAPY, 2021, 29 (04) : 183 - 184
  • [42] AAV8-Mediated Liver Gene Targeting Without Nucleases Rescues Lethality in a Mouse Model of the Crigler-Najjar Syndrome
    Porro, Fabiola
    Bortolussi, Giulia
    Barzel, Adi
    Zentilin, Lorena
    Vodret, Simone
    Bockor, Luka
    Kay, Mark A.
    Muro, Andres F.
    MOLECULAR THERAPY, 2015, 23 : S274 - S274
  • [43] PHARMACOLOGICAL ENHANCEMENT OF HEPATOCYTE ENGRAFTMENT AUGMENTS THE HYPOBILIRUBINEMIC EFFECT OF HEPATOCYTE TRANSPLANTATION IN THE GUNN RAT MODEL OF CRIGLER-NAJJAR SYNDROME TYPE 1
    Avsar, Yesim
    Wang, Xia
    Zhou, Hongchao
    Ding, Jianqiang
    Guha, Chandan
    Fox, Ira
    Roy-Chowdhury, Namita
    Roy-Chowdhury, Jayanta
    HEPATOLOGY, 2011, 54 : 685A - 685A
  • [44] Lipid Nanoparticle Encapsulated mRNA Therapy Corrects Serum Total Bilirubin Levels and Extends Survival in a Mouse Model of Crigler-Najjar Syndrome
    Greig, Jenny A.
    Chorazeczewksi, Joanna
    Smith, Melanie K.
    Coughlan, Kimberly A.
    Martini, Paolo G. V.
    Wilson, James M.
    MOLECULAR THERAPY, 2021, 29 (04) : 241 - 241
  • [45] Free Bilirubin Induces Neuro-Inflammation in an Induced Pluripotent Stem Cell-Derived Cortical Organoid Model of Crigler-Najjar Syndrome
    Pranty, Abida Islam
    Wruck, Wasco
    Adjaye, James
    CELLS, 2023, 12 (18)
  • [46] Liver-targeted, lipid nanoparticle encapsulated mRNA therapy corrects serum total bilirubin levels in a mouse model of Crigler-Najjar syndrome
    Greig, J. A.
    Chorazeczewski, J.
    Smith, M. K.
    Giangrande, P. H.
    Coughlan, K.
    Lukacs, C.
    Jiang, L.
    Martini, P.
    Wilson, J. M.
    HUMAN GENE THERAPY, 2019, 30 (11) : A149 - A149
  • [47] THE METABOLIC EFFECT OF HEPATOCYTE TRANSPLANTATION IS INCREASED BY PHARMACOLOGICAL ENHANCEMENT OF DONOR CELL ENGRAFTMENT IN THE GUNN RAT MODEL OF CRIGLER-NAJJAR SYNDROME TYPE 1
    Avsar, Yesim
    Zhou, Hongchao
    Wang, Xia
    Ding, Jianqiang
    Guha, Chandan
    Fox, Ira
    Roy-Chowdhury, Namita
    Roy-Chowdhury, Jayanta
    TRANSPLANT INTERNATIONAL, 2013, 26 : 117 - 117
  • [48] Can Exchange Transfusion Normalize Serum Levels of Copper, Zinc, and Magnesium in Severe Neonatal Hyperbilirubinemia?
    Aziz, Reem A. Abdel
    El-Mazary, Abdel-Azeem M.
    Saidii, Ahmed A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (02) : E121 - E126
  • [49] CYCLOPHOSPHAMIDE AND NAPROXEN AUGMENT THE METABOLIC EFFECT OF HEPATOCYTE TRANSPLANTATION IN THE GUNN RAT MODEL OF CRIGLER-NAJJAR SYNDROME TYPE 1 BY ENHANCING DONOR CELL ENGRAFTMENT
    Avsar, Y.
    Zhou, H.
    Wang, X.
    Ding, J.
    Guha, C.
    Fox, I. J.
    Roy-Chowdhury, N.
    Roy-Chowdhury, J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S38 - S39
  • [50] Interaction of a Crigler-Najjar syndrome type-I mutation and a Gilbert-type promoter defect results in two grades of hyperbilirubinemia in members of an Amish and a Mennonite kindred of Lancaster County, Pennsylvania.
    Deocharan, B
    Gantla, S
    Morton, DH
    Rizack, L
    Chowdhury, JR
    Chowdhury, NR
    GASTROENTEROLOGY, 1997, 112 (04) : A1255 - A1255